Have a personal or library account? Click to login
Expression and clinical importance of a newly discovered alternative splice variant of the gene for acrosin binding protein found in human brain tumors Cover

Expression and clinical importance of a newly discovered alternative splice variant of the gene for acrosin binding protein found in human brain tumors

Asian Biomedicine
Volume 14 (2020): Issue 6 (December 2020)
By: Baolong Zheng  
Open Access
|Dec 2020

Figures & Tables

Figure 1

Nucleotide and predicted amino acid sequences for the variant of the gene for acrosomal binding protein, ACRBP-V5a. The nucleotide sequence is shown above the predicted amino acid sequence. Numbers on both sides correspond to nucleotides (roman) and amino acid residues (bold italic). The exon 5a is underlined. Two potential N-glycosylation sites are shaded (based on the NetNGlyc1.0 Server).

Figure 2

Expression of the variant of the gene for acrosomal binding protein, ACRBP-V5a and the gene for human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in tissues and cell lines. Left of the DNA ladder (lane M, catalog Nos. MD101-01 or MD104-01; Vazyme Biotech) are the respective numbers of base pairs. Lane N, reaction mixture with H2O alone. (A) Primers located around the human ACRBP-V5a cDNA region are encoded by exons 4–5a and bands of 600 bp represent the splice variant. Lane 1 cDNA of SHG-44 (glioma cell line), lanes 2 and 3 hep G2 and 3 SMMC7721 (both hepatocarcinoma cell lines), respectively. (B) Lanes S1–9 represent tumor tissues of 9 patients and cloned 496 bp of GAPDH cDNA. (C) Positive control testis sample (lane P) derived from SMMC7721 cDNA.

Figure 3

Sequence of the TA cloning result for the variant of the gene for acrosomal binding protein, ACRBP-V5a.

Figure 4

Genomic structure of the gene for acrosomal binding protein, ACRBP. The exons are shown as boxes and the introns as lines. The dark box is exon 5a. Two double-headed arrows represent the cloning sequences of E5, E8, and V5a respectively.

Figure 5

The ratios of ACRBP to ACRBP-V5a in the 3 types of brain tumors. Data represent mean ± SE. A Mann–Whitney U test was used to determine the differences between the 3 different types. N.S.: not significant; **P < 0.01, ***P < 0.001.

Figure 6

Comparison of porcine (full-length) and human (V5a) amino acid sequences for acrosomal binding protein (ACRBP; Clustal Omega alignment program, https://www.ebi.ac.uk/Tools/msa/clustalo/). An * (asterisk) indicates positions that have a single, fully conserved residue. A: (colon) indicates conservation between groups (porcine and human) of strongly similar properties. A. (period) indicates conservation between groups of weakly similar properties.

Analysis of ACRBP-V5a expression and clinicopathological characteristics

Clinicopathological characteristicNo. of mRNA positive patient samples/total samples (%)†PRelative expression Mean ± SE‡P
Sex
  Male21/63 (33.3)0.2946.7 ± 14.00.81
  Female13/29 (44.8)41.7 ± 11.3
Age (years)
  <3420/46 (43.5)0.2050.7 ± 9.50.47
  ≥3414/46 (30.4)36.4 ± 19.1
KPS§
  <7015/34 (44.1)0.2857.6 ± 18.70.24
  ≥7019/58 (32.8)34.7 ± 8.5
Tumor grade‖
  II10/33 (30.3)0.3217.7 ± 3.80.01*
  IV24/59 (40.7)56.1 ± 12.8
Tumor type
  Astrocytoma10/33 (30.3)0.3017.7 ± 3.80.02*
  Glioblastoma10/30 (33.3)50.4 ± 26.1
  Medulloblastoma14/29 (48.3)60.2 ± 12.7
DOI: https://doi.org/10.1515/abm-2020-0033 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Journal RSS Feed
Language: English
Page range: 243 - 252
Published on: Dec 31, 2020
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
protein,
human,
alternative splicing,
antigens,
neoplasm,
brain neoplasms,
cancer–testis antigen,
human
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2020 Baolong Zheng, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 14 (2020): Issue 6 (December 2020)Next article